Global Artificial Intelligence (AI) in Healthcare Market Research and Forecast 2018-2023
Artificial intelligence has penetrated extensively across all possible verticals from financial services to manufacturing and healthcare vertical is no exception. Due to technological advancement, the scope of application of artificial intelligence in care-based applications has widened across the globe. The Artificial Intelligence in Healthcare Market is expected to see a tremendous growth during the forecast period. AI has capabilities to deliver advanced care-related information to physicians to make informed decisions to personalized real-time treatment.
Global AI in healthcare market is expected to grow rapidly due to the several benefits of artificial intelligence technology such as error reduction and digital assistants. Major driver involved in the growth of the market is availability of options to have customized training for trainees and reduction in time and cost associated with research. Other factors that are augmenting the growth of the market include demand for early and accurate detection of diseases, increase in ageing population requires more medical attention and increasing technological advancement such as early decision making. Lack of relevant data and security concerns are the major factor hampering the market growth. However, growing number of start-up due to substantial increase in venture capital investments along with emerging markets such as India, China, and Brazil are expected to fuel the market growth in the near future.
The Artificial Intelligence in Healthcare Market can be segmented on the basis of product offering, technology, applications, and end users. Based on product offering, the market is segmented into software, hardware and service. Based on technology, the market can be segmented into classical machine learning, deep learning, and natural learning process. Based on applications, the global AI in healthcare market can be segmented into diagnosis, biomarkers, virtual nursing assistance, remote monitoring of patients, drug discovery and ai-enabled hospital care. Based on end users, the market can be bifurcated into hospitals and healthcare facilities, personal care and biotechnology and pharmaceutical companies. Among application, the virtual nursing assistance segment holds the largest market share in the global AI in healthcare market. This is majorly attributed to the wide adoption of virtual nursing system in personal care across the globe. The AI solutions are easy-to-use and enables early decision making, which in turn, increasing its demand among the healthcare provider across the globe.
The global AI in healthcare market is further analyzed on the basis of the geographical regions that are contributing in the growth of the market. North America contributes the largest share in the global AI in healthcare market. This is mainly owing to increase in ageing population due to which more medical attention is required to them. Asia Pacific is projected to exhibit the fastest growth rate in the global AI in healthcare market during the forecast period. This is due to increasing per capita income of the population, which makes AI solutions affordable in the emerging economies of the region, which includes India and China.
Some of the key players operating in the global AI in healthcare market Are Arterys, Atomwise, Inc., Bay Labs, Inc., Biobeats, Butterfly Network Inc., Careskore, Cloudmedx Inc., Crosschx, Inc., Deep Genomics, Desktop Genetics Ltd. And Dreamed Diabetes, Ltd. In order to sustain in the competitive market, these players adopt various strategies such as acquisitions, mergers, expansions, joint ventures, and product development, among others. For instance, in 2017, GE Healthcare has partnered with Nvidia to fast-track artificial intelligence adoption in healthcare and with Intel to boost digital imaging.
RESEARCH METHODOLOGY
The market study of AI in healthcare market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.
Secondary sources include:
MARKET SEGMENTATION:
Global AI in healthcare market is segmented on the basis of regional outlook and following segments:
1. Global Artificial Intelligence in Healthcare Market Research and Analysis, By Product Offering
2. Global Artificial Intelligence in Healthcare Market Research and Analysis, By Technology
3. Global Artificial Intelligence in Healthcare Market Research and Analysis, By Applications
4. Global Artificial Intelligence in Healthcare Market Research and Analysis, By End Users
5. Global Artificial Intelligence in Healthcare Market Research and Analysis, By Region
THE REPORT COVERS:
Global AI in healthcare market is expected to grow rapidly due to the several benefits of artificial intelligence technology such as error reduction and digital assistants. Major driver involved in the growth of the market is availability of options to have customized training for trainees and reduction in time and cost associated with research. Other factors that are augmenting the growth of the market include demand for early and accurate detection of diseases, increase in ageing population requires more medical attention and increasing technological advancement such as early decision making. Lack of relevant data and security concerns are the major factor hampering the market growth. However, growing number of start-up due to substantial increase in venture capital investments along with emerging markets such as India, China, and Brazil are expected to fuel the market growth in the near future.
The Artificial Intelligence in Healthcare Market can be segmented on the basis of product offering, technology, applications, and end users. Based on product offering, the market is segmented into software, hardware and service. Based on technology, the market can be segmented into classical machine learning, deep learning, and natural learning process. Based on applications, the global AI in healthcare market can be segmented into diagnosis, biomarkers, virtual nursing assistance, remote monitoring of patients, drug discovery and ai-enabled hospital care. Based on end users, the market can be bifurcated into hospitals and healthcare facilities, personal care and biotechnology and pharmaceutical companies. Among application, the virtual nursing assistance segment holds the largest market share in the global AI in healthcare market. This is majorly attributed to the wide adoption of virtual nursing system in personal care across the globe. The AI solutions are easy-to-use and enables early decision making, which in turn, increasing its demand among the healthcare provider across the globe.
The global AI in healthcare market is further analyzed on the basis of the geographical regions that are contributing in the growth of the market. North America contributes the largest share in the global AI in healthcare market. This is mainly owing to increase in ageing population due to which more medical attention is required to them. Asia Pacific is projected to exhibit the fastest growth rate in the global AI in healthcare market during the forecast period. This is due to increasing per capita income of the population, which makes AI solutions affordable in the emerging economies of the region, which includes India and China.
Some of the key players operating in the global AI in healthcare market Are Arterys, Atomwise, Inc., Bay Labs, Inc., Biobeats, Butterfly Network Inc., Careskore, Cloudmedx Inc., Crosschx, Inc., Deep Genomics, Desktop Genetics Ltd. And Dreamed Diabetes, Ltd. In order to sustain in the competitive market, these players adopt various strategies such as acquisitions, mergers, expansions, joint ventures, and product development, among others. For instance, in 2017, GE Healthcare has partnered with Nvidia to fast-track artificial intelligence adoption in healthcare and with Intel to boost digital imaging.
RESEARCH METHODOLOGY
The market study of AI in healthcare market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.
Secondary sources include:
- Financial reports of companies involved in the market
- Authentic Public Databases such as healthit.gov, nist.gov, digitalhealth.gov and so on.
- Whitepapers, research-papers, and news blogs
- Company websites and their product catalogue
- Supplier Websites such as Alibaba, amazon for pricing analysis
MARKET SEGMENTATION:
Global AI in healthcare market is segmented on the basis of regional outlook and following segments:
1. Global Artificial Intelligence in Healthcare Market Research and Analysis, By Product Offering
2. Global Artificial Intelligence in Healthcare Market Research and Analysis, By Technology
3. Global Artificial Intelligence in Healthcare Market Research and Analysis, By Applications
4. Global Artificial Intelligence in Healthcare Market Research and Analysis, By End Users
5. Global Artificial Intelligence in Healthcare Market Research and Analysis, By Region
THE REPORT COVERS:
- Comprehensive research methodology of global AI in healthcare market
- This report also includes detailed and extensive market overview with key analyst insights
- Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations
- Analysis of regional regulations and other government policies impacting the global AI in healthcare market
- Insights about market determinants which are stimulating the global AI in healthcare market
- Detailed and extensive market segments with regional distribution of forecasted revenues
- Extensive profiles and recent developments of market players
1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
2. MARKET OVERVIEW AND INSIGHTS
2.1. MARKET DEFINITION
2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATIONS
2.3.1. UNITED STATES
2.3.2. CHINA
2.3.3. INDIA
2.3.4. JAPAN
3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. DEMAND FOR EARLY AND ACCURATE DETECTION OF DISEASES
3.1.2. INCREASE IN AGEING POPULATION REQUIRES MORE MEDICAL ATTENTION
3.1.3. AVAILABILITY OF OPTIONS TO HAVE CUSTOMISED TRAINING FOR TRAINEES
3.1.4. REDUCTION IN TIME AND COST ASSOCIATED WITH RESEARCH
3.1.5. INCREASING TECHNOLOGICAL ADVANCEMENT SUCH AS EARLY DECISION MAKING
3.2. RESTRAINTS
3.2.1. LACK OF RELEVANT DATA
3.2.2. SECURITY CONCERNS
3.3. OPPORTUNITIES
3.3.1. GROWING NUMBER OF START-UPS
3.3.2. SIGNIFICANT OPPORTUNITIES IN EMERGING MARKETS SUCH AS INDIA, CHINA, AND BRAZIL
3.3.3. SUBSTANTIAL INCREASE IN VENTURE CAPITAL INVESTMENTS
4. MARKET SEGMENTATION
4.1. AI IN HEALTHCARE MARKET BY END USER
4.1.1. HOSPITALS AND HEALTHCARE FACILITIES
4.1.2. PERSONAL CARE
4.1.3. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
4.2. AI IN HEALTHCARE MARKET BY TECHNOLOGY
4.2.1. CLASSICAL MACHINE LEARNING
4.2.2. DEEP LEARNING
4.2.3. NATURAL LEARNING PROCESS
4.3. AI IN HEALTHCARE MARKET BY PRODUCT OFFERED
4.3.1. SOFTWARE
4.3.2. HARDWARE
4.3.3. SERVICE
4.4. AI IN HEALTHCARE MARKET BY APPLICATION
4.4.1. DIAGNOSIS
4.4.2. BIOMARKERS
4.4.3. VIRTUAL NURSING ASSISTANCE
4.4.4. REMOTE MONITORING OF PATIENTS
4.4.5. DRUG DISCOVERY
4.4.6. AI-ENABLED HOSPITAL CARE
5. COMPETITIVE LANDSCAPE
5.1. MARKET SHARE ANALYSIS
5.2. KEY COMPANY ANALYSIS
6. REGIONAL ANALYSIS
6.1. NORTH AMERICA
6.1.1. UNITED STATES
6.1.2. CANADA
6.1.3. REST OF NORTH AMERICA
6.2. EUROPE
6.2.1. UNITED KINGDOM
6.2.2. FRANCE
6.2.3. GERMANY
6.2.4. ITALY
6.2.5. SPAIN
6.2.6. REST OF EUROPE
6.3. ASIA PACIFIC
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.4. REST OF THE WORLD
7. COMPANY PROFILES
7.1. 3SCAN
7.2. AICURE
7.3. AMARA HEALTH ANALYTICS
7.4. APIXIO
7.5. ARTERYS
7.6. ATOMWISE, INC.
7.7. BAY LABS, INC.
7.8. BIOBEATS
7.9. BUTTERFLY NETWORK INC.
7.10. CARESKORE
7.11. CLOUDMEDX INC.
7.12. CROSSCHX, INC.
7.13. DEEP GENOMICS
7.14. DESKTOP GENETICS LTD.
7.15. DREAMED DIABETES, LTD.
7.16. EMBIBE
7.17. ENLITIC, INC.
7.18. ENSODATA
7.19. FLATIRON HEALTH
7.20. FREENOME INC.
7.21. GE HEALTHCARE
7.22. GENERAL VISION, INC.
7.23. GINGER.IO
7.24. GOOGLE INC.
7.25. HEALINT
7.26. HEALTHCARE FIDELITY INC.
7.27. IBM CORPORATION
7.28. ICARBONX
7.29. INNOPLEXUS
7.30. INTEL CORPORATION
7.31. JOHNSON & JOHNSON SERVICES, INC.
7.32. KONINKLIJKE PHILIPS N.V.
7.33. LOCUS.SH (MARA LABS INC.)
7.34. LUMIATA
7.35. LUNIT INC.
7.36. MAD STREET DEN INC.
7.37. MEDALOGIX
7.38. MEDASENSE BIOMETRICS LTD.
7.39. MEDAWARE SYSTEMS INC.
7.40. MEDTRONIC PLC
7.41. MEDWHAT
7.42. MICROSOFT CORPORATION
7.43. NEXT IT CORP.
7.44. NEXTHEALTH TECHNOLOGIES INC.
7.45. NUMEDII INC.
7.46. NUMERATE
7.47. NVIDIA CORPORATION
7.48. ONCORA MEDICAL
7.49. PAIGE. AI
7.50. PATHWAY GENOMICS
7.51. PICWELL INC.
7.52. PROGNOS
7.53. QVENTUS
7.54. QVENTUS
7.55. RECURSION PHARMACEUTICALS, INC.
7.56. SENSELY
7.57. SENTRIAN
7.58. SENTRIAN
7.59. SIEMENS HEALTHINEERS
7.60. TWOXAR INC.
7.61. VIZ.AI
7.62. WELLFRAME INC.
7.63. WELLTOK, INC.
7.64. YOUR.MD
7.65. ZEBRA MEDICAL
7.66. ZEPHYR HEALTH, INC
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
2. MARKET OVERVIEW AND INSIGHTS
2.1. MARKET DEFINITION
2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATIONS
2.3.1. UNITED STATES
2.3.2. CHINA
2.3.3. INDIA
2.3.4. JAPAN
3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. DEMAND FOR EARLY AND ACCURATE DETECTION OF DISEASES
3.1.2. INCREASE IN AGEING POPULATION REQUIRES MORE MEDICAL ATTENTION
3.1.3. AVAILABILITY OF OPTIONS TO HAVE CUSTOMISED TRAINING FOR TRAINEES
3.1.4. REDUCTION IN TIME AND COST ASSOCIATED WITH RESEARCH
3.1.5. INCREASING TECHNOLOGICAL ADVANCEMENT SUCH AS EARLY DECISION MAKING
3.2. RESTRAINTS
3.2.1. LACK OF RELEVANT DATA
3.2.2. SECURITY CONCERNS
3.3. OPPORTUNITIES
3.3.1. GROWING NUMBER OF START-UPS
3.3.2. SIGNIFICANT OPPORTUNITIES IN EMERGING MARKETS SUCH AS INDIA, CHINA, AND BRAZIL
3.3.3. SUBSTANTIAL INCREASE IN VENTURE CAPITAL INVESTMENTS
4. MARKET SEGMENTATION
4.1. AI IN HEALTHCARE MARKET BY END USER
4.1.1. HOSPITALS AND HEALTHCARE FACILITIES
4.1.2. PERSONAL CARE
4.1.3. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
4.2. AI IN HEALTHCARE MARKET BY TECHNOLOGY
4.2.1. CLASSICAL MACHINE LEARNING
4.2.2. DEEP LEARNING
4.2.3. NATURAL LEARNING PROCESS
4.3. AI IN HEALTHCARE MARKET BY PRODUCT OFFERED
4.3.1. SOFTWARE
4.3.2. HARDWARE
4.3.3. SERVICE
4.4. AI IN HEALTHCARE MARKET BY APPLICATION
4.4.1. DIAGNOSIS
4.4.2. BIOMARKERS
4.4.3. VIRTUAL NURSING ASSISTANCE
4.4.4. REMOTE MONITORING OF PATIENTS
4.4.5. DRUG DISCOVERY
4.4.6. AI-ENABLED HOSPITAL CARE
5. COMPETITIVE LANDSCAPE
5.1. MARKET SHARE ANALYSIS
5.2. KEY COMPANY ANALYSIS
6. REGIONAL ANALYSIS
6.1. NORTH AMERICA
6.1.1. UNITED STATES
6.1.2. CANADA
6.1.3. REST OF NORTH AMERICA
6.2. EUROPE
6.2.1. UNITED KINGDOM
6.2.2. FRANCE
6.2.3. GERMANY
6.2.4. ITALY
6.2.5. SPAIN
6.2.6. REST OF EUROPE
6.3. ASIA PACIFIC
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.4. REST OF THE WORLD
7. COMPANY PROFILES
7.1. 3SCAN
7.2. AICURE
7.3. AMARA HEALTH ANALYTICS
7.4. APIXIO
7.5. ARTERYS
7.6. ATOMWISE, INC.
7.7. BAY LABS, INC.
7.8. BIOBEATS
7.9. BUTTERFLY NETWORK INC.
7.10. CARESKORE
7.11. CLOUDMEDX INC.
7.12. CROSSCHX, INC.
7.13. DEEP GENOMICS
7.14. DESKTOP GENETICS LTD.
7.15. DREAMED DIABETES, LTD.
7.16. EMBIBE
7.17. ENLITIC, INC.
7.18. ENSODATA
7.19. FLATIRON HEALTH
7.20. FREENOME INC.
7.21. GE HEALTHCARE
7.22. GENERAL VISION, INC.
7.23. GINGER.IO
7.24. GOOGLE INC.
7.25. HEALINT
7.26. HEALTHCARE FIDELITY INC.
7.27. IBM CORPORATION
7.28. ICARBONX
7.29. INNOPLEXUS
7.30. INTEL CORPORATION
7.31. JOHNSON & JOHNSON SERVICES, INC.
7.32. KONINKLIJKE PHILIPS N.V.
7.33. LOCUS.SH (MARA LABS INC.)
7.34. LUMIATA
7.35. LUNIT INC.
7.36. MAD STREET DEN INC.
7.37. MEDALOGIX
7.38. MEDASENSE BIOMETRICS LTD.
7.39. MEDAWARE SYSTEMS INC.
7.40. MEDTRONIC PLC
7.41. MEDWHAT
7.42. MICROSOFT CORPORATION
7.43. NEXT IT CORP.
7.44. NEXTHEALTH TECHNOLOGIES INC.
7.45. NUMEDII INC.
7.46. NUMERATE
7.47. NVIDIA CORPORATION
7.48. ONCORA MEDICAL
7.49. PAIGE. AI
7.50. PATHWAY GENOMICS
7.51. PICWELL INC.
7.52. PROGNOS
7.53. QVENTUS
7.54. QVENTUS
7.55. RECURSION PHARMACEUTICALS, INC.
7.56. SENSELY
7.57. SENTRIAN
7.58. SENTRIAN
7.59. SIEMENS HEALTHINEERS
7.60. TWOXAR INC.
7.61. VIZ.AI
7.62. WELLFRAME INC.
7.63. WELLTOK, INC.
7.64. YOUR.MD
7.65. ZEBRA MEDICAL
7.66. ZEPHYR HEALTH, INC
LIST OF TABLES
TABLE 1 GLOBAL AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 2 GLOBAL AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY END USER 2017-2023 ($ MILLION)
TABLE 3 GLOBAL HOSPITALS AND HEALTHCARE FACILITIES MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
TABLE 4 GLOBAL PERSONAL CARE MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
TABLE 5 GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
TABLE 6 GLOBAL AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY 2017-2023 ($ MILLION)
TABLE 7 GLOBAL CLASSICAL MACHINE LEARNING MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
TABLE 8 GLOBAL DEEP LEARNING MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
TABLE 9 GLOBAL NATURAL LEARNING PROCESS MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
TABLE 10 GLOBAL AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY PRODUCT OFFERED 2017-2023 ($ MILLION)
TABLE 11 GLOBAL SOFTWARE MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
TABLE 12 GLOBAL HARDWARE MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
TABLE 13 GLOBAL SERVICE MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
TABLE 14 GLOBAL AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY APPLICATION 2017-2023 ($ MILLION)
TABLE 15 GLOBAL DIAGNOSIS MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
TABLE 16 GLOBAL BIOMARKERS MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
TABLE 17 GLOBAL VIRTUAL NURSING ASSISTANCE MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
TABLE 18 GLOBAL REMOTE MONITORING OF PATIENTS MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
TABLE 19 GLOBAL DRUG DISCOVERY MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
TABLE 20 GLOBAL AI-ENABLED HOSPITAL CARE MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
TABLE 21 NORTH AMERICA AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY END USER 2017-2023 ($ MILLION)
TABLE 22 NORTH AMERICA AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 23 NORTH AMERICA AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY 2017-2023 ($ MILLION)
TABLE 24 NORTH AMERICA AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY PRODUCT OFFERED 2017-2023 ($ MILLION)
TABLE 25 NORTH AMERICA AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY APPLICATION 2017-2023 ($ MILLION)
TABLE 26 EUROPE AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 27 EUROPE AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY PRODUCT OFFERED 2017-2023 ($ MILLION)
TABLE 28 EUROPE AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY END USER 2017-2023 ($ MILLION)
TABLE 29 EUROPE AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY 2017-2023 ($ MILLION)
TABLE 30 EUROPE AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY APPLICATION 2017-2023 ($ MILLION)
TABLE 31 APAC AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 32 APAC AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY PRODUCT OFFERED 2017-2023 ($ MILLION)
TABLE 33 APAC AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY END USER 2017-2023 ($ MILLION)
TABLE 34 APAC AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY 2017-2023 ($ MILLION)
TABLE 35 APAC AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY APPLICATION 2017-2023 ($ MILLION)
TABLE 36 REST OF THE WORLD AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY 2017-2023 ($ MILLION)
TABLE 37 REST OF THE WORLD AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY PRODUCT OFFERED 2017-2023 ($ MILLION)
TABLE 38 REST OF THE WORLD AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY END USER 2017-2023 ($ MILLION)
TABLE 39 REST OF THE WORLD AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY APPLICATION 2017-2023 ($ MILLION)
TABLE 1 GLOBAL AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 2 GLOBAL AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY END USER 2017-2023 ($ MILLION)
TABLE 3 GLOBAL HOSPITALS AND HEALTHCARE FACILITIES MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
TABLE 4 GLOBAL PERSONAL CARE MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
TABLE 5 GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
TABLE 6 GLOBAL AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY 2017-2023 ($ MILLION)
TABLE 7 GLOBAL CLASSICAL MACHINE LEARNING MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
TABLE 8 GLOBAL DEEP LEARNING MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
TABLE 9 GLOBAL NATURAL LEARNING PROCESS MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
TABLE 10 GLOBAL AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY PRODUCT OFFERED 2017-2023 ($ MILLION)
TABLE 11 GLOBAL SOFTWARE MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
TABLE 12 GLOBAL HARDWARE MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
TABLE 13 GLOBAL SERVICE MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
TABLE 14 GLOBAL AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY APPLICATION 2017-2023 ($ MILLION)
TABLE 15 GLOBAL DIAGNOSIS MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
TABLE 16 GLOBAL BIOMARKERS MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
TABLE 17 GLOBAL VIRTUAL NURSING ASSISTANCE MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
TABLE 18 GLOBAL REMOTE MONITORING OF PATIENTS MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
TABLE 19 GLOBAL DRUG DISCOVERY MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
TABLE 20 GLOBAL AI-ENABLED HOSPITAL CARE MARKET RESEARCH AND ANALYSIS 2017-2023 ($ MILLION)
TABLE 21 NORTH AMERICA AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY END USER 2017-2023 ($ MILLION)
TABLE 22 NORTH AMERICA AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 23 NORTH AMERICA AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY 2017-2023 ($ MILLION)
TABLE 24 NORTH AMERICA AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY PRODUCT OFFERED 2017-2023 ($ MILLION)
TABLE 25 NORTH AMERICA AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY APPLICATION 2017-2023 ($ MILLION)
TABLE 26 EUROPE AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 27 EUROPE AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY PRODUCT OFFERED 2017-2023 ($ MILLION)
TABLE 28 EUROPE AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY END USER 2017-2023 ($ MILLION)
TABLE 29 EUROPE AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY 2017-2023 ($ MILLION)
TABLE 30 EUROPE AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY APPLICATION 2017-2023 ($ MILLION)
TABLE 31 APAC AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 32 APAC AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY PRODUCT OFFERED 2017-2023 ($ MILLION)
TABLE 33 APAC AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY END USER 2017-2023 ($ MILLION)
TABLE 34 APAC AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY 2017-2023 ($ MILLION)
TABLE 35 APAC AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY APPLICATION 2017-2023 ($ MILLION)
TABLE 36 REST OF THE WORLD AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY 2017-2023 ($ MILLION)
TABLE 37 REST OF THE WORLD AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY PRODUCT OFFERED 2017-2023 ($ MILLION)
TABLE 38 REST OF THE WORLD AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY END USER 2017-2023 ($ MILLION)
TABLE 39 REST OF THE WORLD AI IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY APPLICATION 2017-2023 ($ MILLION)
LIST OF FIGURES
FIGURE 1 GLOBAL AI IN HEALTHCARE MARKET SHARE BY PRODUCT OFFERED 2017 VS 2023 (IN %)
FIGURE 2 GLOBAL AI IN HEALTHCARE MARKET SHARE BY TECHNOLOGY 2017 VS 2023 (IN %)
FIGURE 3 GLOBAL AI IN HEALTH MARKET SHARE BY APPLICATION 2017 VS 2023 (IN %)
FIGURE 4 GLOBAL AI IN HEALTH MARKET SHARE BY END USER 2017 VS 2023 (IN %)
FIGURE 5 NORTH AMERICA AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)
FIGURE 6 US AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)
FIGURE 7 CANADA AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)
FIGURE 8 EUROPEAN AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)
FIGURE 9 UK AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)
FIGURE 10 FRANCE AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)
FIGURE 11 GERMANY AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)
FIGURE 12 ITALY AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)
FIGURE 13 SPAIN AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)F
FIGURE 14 ROE AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)
FIGURE 15 ASIA PACIFIC AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)
FIGURE 16 INDIA AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)
FIGURE 17 CHINA AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)
FIGURE 18 JAPAN AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)
FIGURE 19 REST OF APAC AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)
FIGURE 20 REST OF THE WORLD AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)
COMPANIES MENTIONED
1. 3SCAN
2. AICURE
3. AMARA HEALTH ANALYTICS
4. APIXIO
5. ARTERYS
6. ATOMWISE, INC.
7. BAY LABS, INC.
8. BIOBEATS
9. BUTTERFLY NETWORK INC.
10. CARESKORE
11. CLOUDMEDX INC.
12. CROSSCHX, INC.
13. DEEP GENOMICS
14. DESKTOP GENETICS LTD.
15. DREAMED DIABETES, LTD.
16. EMBIBE
17. ENLITIC, INC.
18. ENSODATA
19. FLATIRON HEALTH
20. FREENOME INC.
21. GE HEALTHCARE
22. GENERAL VISION, INC.
23. GINGER.IO
24. GOOGLE INC.
25. HEALINT
26. HEALTHCARE FIDELITY INC.
27. IBM CORPORATION
28. ICARBONX
29. INNOPLEXUS
30. INTEL CORPORATION
31. JOHNSON & JOHNSON SERVICES, INC.
32. KONINKLIJKE PHILIPS N.V.
33. LOCUS.SH (MARA LABS INC.)
34. LUMIATA
35. LUNIT INC.
36. MAD STREET DEN INC.
37. MEDALOGIX
38. MEDASENSE BIOMETRICS LTD.
39. MEDAWARE SYSTEMS INC.
40. MEDTRONIC PLC
41. MEDWHAT
42. MICROSOFT CORPORATION
43. NEXT IT CORP.
44. NEXTHEALTH TECHNOLOGIES INC.
45. NUMEDII INC.
46. NUMERATE
47. NVIDIA CORPORATION
48. ONCORA MEDICAL
49. PAIGE. AI
50. PATHWAY GENOMICS
51. PICWELL INC.
52. PROGNOS
53. QVENTUS
54. QVENTUS
55. RECURSION PHARMACEUTICALS, INC.
56. SENSELY
57. SENTRIAN
58. SENTRIAN
59. SIEMENS HEALTHINEERS
60. TWOXAR INC.
61. VIZ.AI
62. WELLFRAME INC.
63. WELLTOK, INC.
64. YOUR.MD
65. ZEBRA MEDICAL
66. ZEPHYR HEALTH, INC
FIGURE 1 GLOBAL AI IN HEALTHCARE MARKET SHARE BY PRODUCT OFFERED 2017 VS 2023 (IN %)
FIGURE 2 GLOBAL AI IN HEALTHCARE MARKET SHARE BY TECHNOLOGY 2017 VS 2023 (IN %)
FIGURE 3 GLOBAL AI IN HEALTH MARKET SHARE BY APPLICATION 2017 VS 2023 (IN %)
FIGURE 4 GLOBAL AI IN HEALTH MARKET SHARE BY END USER 2017 VS 2023 (IN %)
FIGURE 5 NORTH AMERICA AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)
FIGURE 6 US AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)
FIGURE 7 CANADA AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)
FIGURE 8 EUROPEAN AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)
FIGURE 9 UK AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)
FIGURE 10 FRANCE AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)
FIGURE 11 GERMANY AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)
FIGURE 12 ITALY AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)
FIGURE 13 SPAIN AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)F
FIGURE 14 ROE AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)
FIGURE 15 ASIA PACIFIC AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)
FIGURE 16 INDIA AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)
FIGURE 17 CHINA AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)
FIGURE 18 JAPAN AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)
FIGURE 19 REST OF APAC AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)
FIGURE 20 REST OF THE WORLD AI IN HEALTHCARE MARKET SIZE 2017-2023 ($MILLION)
COMPANIES MENTIONED
1. 3SCAN
2. AICURE
3. AMARA HEALTH ANALYTICS
4. APIXIO
5. ARTERYS
6. ATOMWISE, INC.
7. BAY LABS, INC.
8. BIOBEATS
9. BUTTERFLY NETWORK INC.
10. CARESKORE
11. CLOUDMEDX INC.
12. CROSSCHX, INC.
13. DEEP GENOMICS
14. DESKTOP GENETICS LTD.
15. DREAMED DIABETES, LTD.
16. EMBIBE
17. ENLITIC, INC.
18. ENSODATA
19. FLATIRON HEALTH
20. FREENOME INC.
21. GE HEALTHCARE
22. GENERAL VISION, INC.
23. GINGER.IO
24. GOOGLE INC.
25. HEALINT
26. HEALTHCARE FIDELITY INC.
27. IBM CORPORATION
28. ICARBONX
29. INNOPLEXUS
30. INTEL CORPORATION
31. JOHNSON & JOHNSON SERVICES, INC.
32. KONINKLIJKE PHILIPS N.V.
33. LOCUS.SH (MARA LABS INC.)
34. LUMIATA
35. LUNIT INC.
36. MAD STREET DEN INC.
37. MEDALOGIX
38. MEDASENSE BIOMETRICS LTD.
39. MEDAWARE SYSTEMS INC.
40. MEDTRONIC PLC
41. MEDWHAT
42. MICROSOFT CORPORATION
43. NEXT IT CORP.
44. NEXTHEALTH TECHNOLOGIES INC.
45. NUMEDII INC.
46. NUMERATE
47. NVIDIA CORPORATION
48. ONCORA MEDICAL
49. PAIGE. AI
50. PATHWAY GENOMICS
51. PICWELL INC.
52. PROGNOS
53. QVENTUS
54. QVENTUS
55. RECURSION PHARMACEUTICALS, INC.
56. SENSELY
57. SENTRIAN
58. SENTRIAN
59. SIEMENS HEALTHINEERS
60. TWOXAR INC.
61. VIZ.AI
62. WELLFRAME INC.
63. WELLTOK, INC.
64. YOUR.MD
65. ZEBRA MEDICAL
66. ZEPHYR HEALTH, INC
